Tumor cells have co-opted this PD-1/PDL-1 regulatory mechanism, normally designed to prevent autoimmune attacks, and instead overexpress PDL-1 to avoid immunologic surveillance and to facilitate cancer growth (Patel and Kurzrock, 2015). The gene discussed is CD274; the disease is cancer.